BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29499154)

  • 1. Vangl2/RhoA Signaling Pathway Regulates Stem Cell Self-Renewal Programs and Growth in Rhabdomyosarcoma.
    Hayes MN; McCarthy K; Jin A; Oliveira ML; Iyer S; Garcia SP; Sindiri S; Gryder B; Motala Z; Nielsen GP; Borg JP; van de Rijn M; Malkin D; Khan J; Ignatius MS; Langenau DM
    Cell Stem Cell; 2018 Mar; 22(3):414-427.e6. PubMed ID: 29499154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wnt receptor Ryk plays a role in mammalian planar cell polarity signaling.
    Macheda ML; Sun WW; Kugathasan K; Hogan BM; Bower NI; Halford MM; Zhang YF; Jacques BE; Lieschke GJ; Dabdoub A; Stacker SA
    J Biol Chem; 2012 Aug; 287(35):29312-23. PubMed ID: 22773843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma.
    Ignatius MS; Hayes MN; Lobbardi R; Chen EY; McCarthy KM; Sreenivas P; Motala Z; Durbin AD; Molodtsov A; Reeder S; Jin A; Sindiri S; Beleyea BC; Bhere D; Alexander MS; Shah K; Keller C; Linardic CM; Nielsen PG; Malkin D; Khan J; Langenau DM
    Cell Rep; 2017 Jun; 19(11):2304-2318. PubMed ID: 28614716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma.
    Chen EY; DeRan MT; Ignatius MS; Grandinetti KB; Clagg R; McCarthy KM; Lobbardi RM; Brockmann J; Keller C; Wu X; Langenau DM
    Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5349-54. PubMed ID: 24706870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planar cell polarity proteins differentially regulate extracellular matrix organization and assembly during zebrafish gastrulation.
    Dohn MR; Mundell NA; Sawyer LM; Dunlap JA; Jessen JR
    Dev Biol; 2013 Nov; 383(1):39-51. PubMed ID: 24021482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma.
    Dyberg C; Papachristou P; Haug BH; Lagercrantz H; Kogner P; Ringstedt T; Wickström M; Johnsen JI
    BMC Cancer; 2016 Mar; 16():259. PubMed ID: 27036398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma.
    Saini M; Verma A; Mathew SJ
    Cell Death Dis; 2018 Feb; 9(2):237. PubMed ID: 29445192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PDZ domain protein Mcc is a novel effector of non-canonical Wnt signaling during convergence and extension in zebrafish.
    Young T; Poobalan Y; Tan EK; Tao S; Ong S; Wehner P; Schwenty-Lara J; Lim CY; Sadasivam A; Lovatt M; Wang ST; Ali Y; Borchers A; Sampath K; Dunn NR
    Development; 2014 Sep; 141(18):3505-16. PubMed ID: 25183869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dynamic intracellular distribution of Vangl2 accompanies cell polarization during zebrafish gastrulation.
    Roszko I; S Sepich D; Jessen JR; Chandrasekhar A; Solnica-Krezel L
    Development; 2015 Jul; 142(14):2508-20. PubMed ID: 26062934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vangl2 acts via RhoA signaling to regulate polarized cell movements during development of the proximal outflow tract.
    Phillips HM; Murdoch JN; Chaudhry B; Copp AJ; Henderson DJ
    Circ Res; 2005 Feb; 96(3):292-9. PubMed ID: 15637299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetry of VANGL2 in migrating lymphocytes as a tool to monitor activity of the mammalian WNT/planar cell polarity pathway.
    Kaucká M; Petersen J; Janovská P; Radaszkiewicz T; Smyčková L; Daulat AM; Borg JP; Schulte G; Bryja V
    Cell Commun Signal; 2015 Jan; 13():2. PubMed ID: 25627785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer.
    Puvirajesinghe TM; Bertucci F; Jain A; Scerbo P; Belotti E; Audebert S; Sebbagh M; Lopez M; Brech A; Finetti P; Charafe-Jauffret E; Chaffanet M; Castellano R; Restouin A; Marchetto S; Collette Y; Gonçalvès A; Macara I; Birnbaum D; Kodjabachian L; Johansen T; Borg JP
    Nat Commun; 2016 Jan; 7():10318. PubMed ID: 26754771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
    Skrzypek K; Kusienicka A; Szewczyk B; Adamus T; Lukasiewicz E; Miekus K; Majka M
    Oncotarget; 2015 Oct; 6(31):31378-98. PubMed ID: 26384300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel small molecule DMAMCL induces differentiation in rhabdomyosarcoma by downregulating of DLL1.
    Li Q; Chen Y; Chen Y; Hua Z; Gong B; Liu Z; Thiele CJ; Li Z
    Biomed Pharmacother; 2024 May; 174():116562. PubMed ID: 38626518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and temporal requirements of Wnt/PCP protein Vangl2 function for convergence and extension movements and facial branchiomotor neuron migration in zebrafish.
    Pan X; Sittaramane V; Gurung S; Chandrasekhar A
    Mech Dev; 2014 Feb; 131():1-14. PubMed ID: 24333599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vangl1 and Vangl2: planar cell polarity components with a developing role in cancer.
    Hatakeyama J; Wald JH; Printsev I; Ho HY; Carraway KL
    Endocr Relat Cancer; 2014 Oct; 21(5):R345-56. PubMed ID: 24981109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RBPJ is a novel target for rhabdomyosarcoma therapy.
    Nagao H; Setoguchi T; Kitamoto S; Ishidou Y; Nagano S; Yokouchi M; Abematsu M; Kawabata N; Maeda S; Yonezawa S; Komiya S
    PLoS One; 2012; 7(7):e39268. PubMed ID: 22792167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state.
    Hsu JY; Danis EP; Nance S; O'Brien JH; Gustafson AL; Wessells VM; Goodspeed AE; Talbot JC; Amacher SL; Jedlicka P; Black JC; Costello JC; Durbin AD; Artinger KB; Ford HL
    Cell Rep; 2022 Feb; 38(5):110323. PubMed ID: 35108532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.
    Nitzki F; Cuvelier N; Dräger J; Schneider A; Braun T; Hahn H
    Oncogene; 2016 Jun; 35(22):2923-31. PubMed ID: 26387541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core planar cell polarity genes
    Feng X; Ye Y; Zhang J; Zhang Y; Zhao S; Mak JCW; Otomo N; Zhao Z; Niu Y; Yonezawa Y; Li G; Lin M; Li X; Cheung PWH; Xu K; Takeda K; Wang S; Xie J; Kotani T; Choi VNT; Song YQ; Yang Y; Luk KDK; Lee KS; Li Z; Li PS; Leung CYH; Lin X; Wang X; Qiu G; ; Watanabe K; ; Wu Z; Posey JE; Ikegawa S; Lupski JR; Cheung JPY; Zhang TJ; Gao B; Wu N
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2310283121. PubMed ID: 38669183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.